BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
Indications
/
Colorectal Cancer
Colorectal Cancer
16 competing products in clinical development for Colorectal Cancer.
Pipeline by Phase
Phase 1
3
Phase 1/2
3
Phase 2
7
Phase 2/3
3
All Products (16)
Product
Company
Stage
Status
Hype
ONO-4578 + Opdivo® + Oxaliplatin + 5-Fluorouracil + Bevacizumab + Leucovorin
Ono Pharmaceutical
Phase 2
Recruiting
42
FOLFIRI + FOLFOX-4 + FOLFIRI-HD + FOLFOX-7 + FOLFIRINOX
Chugai Pharmaceutical
Phase 2/3
Completed
38
CPT-11 and TS-1 + CPT-11, 5-FU and l-LV
Daiichi Sankyo
Phase 2/3
Completed
38
Nivolumab + Oxaliplatin + Leucovorin + Fluorouracil + Bevacizumab
Ono Pharmaceutical
Phase 2/3
Completed
38
Cetuximab + Oxaliplatin + Capecitabine
Eli Lilly
Phase 2
Completed
35
ALIMTA + Oxaliplatin
Eli Lilly
Phase 2
Completed
35
CS7017 + irinotecan, leucovorin, and 5-fluorouracil (5-FU) (FOLFIRI)
Daiichi Sankyo
Phase 2
Completed
35
DJ-927
Daiichi Sankyo
Phase 2
Completed
35
E7070
Eisai
Phase 2
Completed
35
ONO-4578 + ONO-4538 + Capecitabine + Oxaliplatin + Fluorouracil + Calcium Levofolinate Hydrateb + Bevacizumab
Ono Pharmaceutical
Phase 1
Active
33
Bevacizumab + Oxaliplatin + Capecitabine
Chugai Pharmaceutical
Phase 1/2
Completed
32
Dacogen™ (decitabine) + Vectibix® (panitumumab)
Eisai
Phase 1
Completed
29
KRN330
Kyowa Kirin
Phase 1
Completed
29
CS-7017 + Placebo
Daiichi Sankyo
Phase 2
Terminated
27
FOLFIRI + E7820 + Bevacizumab
Eisai
Phase 1/2
Terminated
24
KRN330 + Irinotecan
Kyowa Kirin
Phase 1/2
Terminated
24